NM_014629.4:c.38-81G>T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014629.4(ARHGEF10):c.38-81G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.45 ( 9063 hom., cov: 18)
Exomes 𝑓: 0.40 ( 27119 hom. )
Failed GnomAD Quality Control
Consequence
ARHGEF10
NM_014629.4 intron
NM_014629.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.598
Genes affected
ARHGEF10 (HGNC:14103): (Rho guanine nucleotide exchange factor 10) This gene encodes a Rho guanine nucleotide exchange factor (GEF). Rho GEFs regulate the activity of small Rho GTPases by stimulating the exchange of guanine diphosphate (GDP) for guanine triphosphate (GTP) and may play a role in neural morphogenesis. Mutations in this gene are associated with slowed nerve conduction velocity (SNCV). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.06).
BP6
Variant 8-1857879-G-T is Benign according to our data. Variant chr8-1857879-G-T is described in ClinVar as [Benign]. Clinvar id is 1292935.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.498 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF10 | ENST00000349830.8 | c.38-81G>T | intron_variant | Intron 2 of 28 | 1 | NM_014629.4 | ENSP00000340297.3 | |||
KBTBD11-OT1 | ENST00000635855.1 | n.628-81G>T | intron_variant | Intron 3 of 29 | 5 | ENSP00000489726.1 |
Frequencies
GnomAD3 genomes AF: 0.454 AC: 51372AN: 113250Hom.: 9057 Cov.: 18
GnomAD3 genomes
AF:
AC:
51372
AN:
113250
Hom.:
Cov.:
18
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.397 AC: 189739AN: 477786Hom.: 27119 AF XY: 0.399 AC XY: 101237AN XY: 253612
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
189739
AN:
477786
Hom.:
AF XY:
AC XY:
101237
AN XY:
253612
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.454 AC: 51401AN: 113320Hom.: 9063 Cov.: 18 AF XY: 0.456 AC XY: 25080AN XY: 54956
GnomAD4 genome
AF:
AC:
51401
AN:
113320
Hom.:
Cov.:
18
AF XY:
AC XY:
25080
AN XY:
54956
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 10, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at